irinotecan has been researched along with Mouth Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Carvalho Fraga, CA; de Souza, MG; Farias, LC; Guimarães, ALS; Guimarães, TA; Jones, KM; Xavier, GM | 1 |
| Amano, O; Hashimoto, K; Hirano, K; Kishino, K; Sakagami, H; Shimada, J; Tamura, N | 1 |
1 review(s) available for irinotecan and Mouth Neoplasms
| Article | Year |
|---|---|
Pathways Related to the Anti-Cancer Effects of Metabolites Derived from Cerrado Biome Native Plants: An Update and Bioinformatics Analysis on Oral Squamous Cell Carcinoma.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Brazil; Carcinogenesis; Carcinoma, Squamous Cell; Cell Proliferation; Computational Biology; Etoposide; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Mouth Neoplasms; Neoplasm Proteins; Paclitaxel; Plant Extracts; Plants, Medicinal; Vinblastine | 2021 |
1 other study(ies) available for irinotecan and Mouth Neoplasms
| Article | Year |
|---|---|
Analysis of type of cell death induced by topoisomerase inhibitor SN-38 in human oral squamous cell carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Camptothecin; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Fragmentation; HL-60 Cells; Humans; In Situ Nick-End Labeling; Irinotecan; Mouth Neoplasms; Topoisomerase Inhibitors | 2012 |